Boaz Hirshberg

1 ta ish

AstraZeneca (United States)

1. Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk

   Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald +10

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.679649